Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ0L4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,550
Award facts
- Contract value 100% obligated
- $49,549.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on August 27, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $49,549.81 for the supply of Dupixent 300 mg/2 mL pen injections (2 mL units). The contract represents a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively bid. Performance will be completed by August 28, 2025, with fulfillment occurring at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor in the DLA's Medical Supply Chain, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to military healthcare systems and other federal agencies. Dupixent is a biologic immunosuppressant used in the treatment of eczema, asthma, and other inflammatory conditions, making this delivery order consistent with the company's established role in providing specialty pharmaceutical products to support Department of Defense healthcare operations. The contract's one-day completion timeline reflects the expedited nature of this particular supply delivery within the broader pharmaceutical support vehicle.
Quick answers
Who was awarded contract SPE2DB25FQ0L4?
SPE2DB25FQ0L4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FQ0L4 worth?
The government has obligated $49,550 on SPE2DB25FQ0L4.
Is contract SPE2DB25FQ0L4 an order under another contract?
Yes. SPE2DB25FQ0L4 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ0L4 competed?
The extent of competition for SPE2DB25FQ0L4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award